These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17963739)

  • 1. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Li TJ; Lu KH
    Clin Chim Acta; 2008 Jan; 387(1-2):90-6. PubMed ID: 17963739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Lee CY; Chou MC; Lu KH
    Clin Chim Acta; 2006 Oct; 372(1-2):167-72. PubMed ID: 16756968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
    Yang SF; Hsieh YS; Lue KH; Chu SC; Chang IC; Lu KH
    Clin Biochem; 2008 Jan; 41(1-2):109-16. PubMed ID: 17996201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
    J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts.
    Pelletier JP; Mineau F; Fernandes J; Kiansa K; Ranger P; Martel-Pelletier J
    Clin Exp Rheumatol; 1997; 15(4):393-8. PubMed ID: 9272300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes.
    Sadowski T; Steinmeyer J
    Inflamm Res; 2002 Aug; 51(8):427-33. PubMed ID: 12234061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro.
    Asano K; Sakai M; Matsuda T; Tanaka H; Fujii K; Hisamitsu T
    J Pharm Pharmacol; 2006 Mar; 58(3):359-66. PubMed ID: 16536903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.
    Sadowski T; Steinmeyer J
    Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.
    Budsberg SC; Stoker AM; Johnston SA; Liska W; Reno LR; Cook JL
    Am J Vet Res; 2013 Sep; 74(9):1198-205. PubMed ID: 23977892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
    Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement.
    Hsieh YS; Yang SF; Chu SC; Chen PN; Chou MC; Hsu MC; Lu KH
    Arthroscopy; 2004 May; 20(5):482-8. PubMed ID: 15122138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Wu CL; Lu KH
    Connect Tissue Res; 2004; 45(3):142-50. PubMed ID: 15512768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.